Healthcare

PharmaDrug (OTC: LMLLF) Announces Positive Findings for the Combination of Cepharanthine and Frontline Chemotherapy for IND-Enabling Esophageal Cancer Study

Results show that oral cepharanthine plus paclitaxel (combination therapy) significantly reduced tumor volume and increased tumor growth inhibition at day 28, the final day of dosing compared to paclitaxel alone (p=0.0049) Dose range finding demonstrates […]

Financials

XTM (OTC: XTMIF) Launches Three Large U.S. Restaurant Chains to Its Today™ Program for Digital Staff Payout

Payment Initiated for Hospitality Staff Working Across 50+ U.S Rooftops MIAMI & TORONTO, June 14, 2022—-XTM, Inc. (“XTM” or the “Company”) (QB: XTMIF / CSE:PAID / FSE:7XT), a Miami and Toronto-based Fintech company in the […]

Healthcare

Nova Mentis (OTC: NMLSF) and University of Central Florida to Develop Saliva Serotonin Assay

Vancouver, British Columbia–(Newsfile Corp. – June 9, 2022) – Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF) (“NOVA” or the “Company”), a biotechnology company and global leader in first-in-class psilocybin-based therapeutics and complementary diagnostics […]

No Picture
Newsmakers

Applied UV (NASDAQ: AUVI) Announces International Dealer Awarded Sole Source Provider Contract for Airocide’s FDA Class II Listed Medical Device

Airocide to be Deployed in Pakistan Government Hospitals Expands Global Footprint with Distribution Now in 52 Countries MOUNT VERNON, N.Y., June 09, 2022–Applied UV, Inc. (NASDAQ: AUVI) (“Applied UV” or the “Company”), a pathogen elimination technology company […]

No Picture
Healthcare

Stealth BioTherapeutics (NASDAQ: MITO) Presents New SBT-272 Data Demonstrating Improvement in Upper Motor Neuron Function in ALS Disease Model at Keystone Neurodegeneration Symposium

SBT-272 improved neuronal health, superior to other approved and investigational agents Phase 1 study to evaluate safety and tolerability of SBT-272 in healthy volunteers is underway BOSTON, June 8, 2022 — Stealth BioTherapeutics Corp (NASDAQ: MITO), […]

No Picture
Healthcare

FDA Advisory Committee Recommends Emergency Use Authorization of Novavax (NASDAQ: NVAX) COVID-19 Vaccine for People Aged 18 Years and Older

Novavax COVID-19 vaccine receives positive vote from U.S. Food and Drug Administration Vaccines and Related Biological Products Advisory Committee If Emergency Use Authorization is granted by the FDA, the Novavax COVID-19 vaccine would become the […]

Healthcare

Nova Mentis (OTC: NMLSF) Receives Controlled Substances Export Approval From The U.S. DEA For The Company’s Proprietary Psilocybin Drug NM 1001

Vancouver, British Columbia– June 7, 2022 – Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF) (“NOVA” or the “Company”), a biotechnology company and global leader in first-in-class psilocybin-based therapeutics and complementary diagnostics for neuroinflammatory […]

Newsmakers

DeepMarkit (OTC: MKTDF) Contributes Response to Current Industry Dialogue Regarding Tokenization of Carbon Credits

The Company’s MintCarbon.io platform mints only 100% verified carbon credits registered on the Gold Standard or Verra Registries and Other Reputable Registries Retired, Expired or Otherwise Inferior Credits are not Eligible for Minting on MintCarbon.io […]

Newsmakers

DeepMarkit (OTC: MKTDF) Welcomes Added Validation of its Business Model as Venture Capital Firms Lead US$70 Million Investment in Recent Industry Deal

VC Firms Andreessen Horowitz, General Catalyst and Samsung Next, to name a few, backed the latest large deal that is drawing attention to the carbon credit industry Flowcarbon’s ability to raise US$70 Million demonstrates a growing level […]

No Picture
Healthcare

Kiromic BioPharma (NASDAQ: KRBP) Significantly Expands Gamma Delta T cell Product Pipeline with New Sponsored Research Agreement

In Vivo Preclinical Data Expected to Enable Three New IND Applications to Evaluate Company’s Gamma Delta T cell Product Candidates Procel™, Isocel™, and Deltacel™ HOUSTON, June 07, 2022—-Kiromic BioPharma, Inc. (NASDAQ: KRBP), a clinical-stage biotherapeutics company […]